In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Invatec: Translating Global Success in Vascular Devices to the US Market

Executive Summary

Invatec has grown to be the leading native European interventional vascular device company and has now set its sights on the US market. By focusing first on peripherals and following with drug-eluting balloons, not stents, Invatec is looking to compete against the major device companies on their home turf.

Related Content

Lutonix: Back To The Future With Drug-Coated Balloons
US Markets for Peripheral Stents Get AAA Rating
Device M&A Poised For A Strong Year
Medtronic: Doing Just What the Doctors Order
Cappella: Can a New Twist On An Old Idea Solve the Bifurcation Challenge?
Drug-Eluting Balloons: Coming of Age in the Periphery
Tryton Medical: Going Against the Flow in Bifurcated Stents
Embolic Protection: Unmet Clinical Need or Unneeded Technology
B. Braun's Bet on Balloons
Krauth Medical: Finding a Way in the New German Market


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts